Amelioration of Murine Diabetic Nephropathy with a SGLT2 Inhibitor Is Associated with Suppressing Abnormal Expression of Hypoxia-Inducible Factors

by Arakawa, K., Fukatsu, A., Inada, A., Inada, O., Nabeshima, Y.-I, Yasunami, Y.
Published 2022

Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (...

by Amaro, A.J.J, Badimon, J.J, Berrospi, P., Bryce, A., Cobos S., L., Duran, M., Gomez-Mancebo, J.R, González, J.J.R, Lanas, F., Lara, J., Libby, P., López-Jaramillo, P., Lorenzatti, A., Lozada, A.F, Medina-Palomino, F.A, Miranda, D., Piskorz, D., Ponte-Negretti, C.I, Puente-Barragan, A., Rodrigo, A.K, Santos, R.D, Toth, P.P, Ullauri-Solórzano, V.E, Urina-Triana, M., Valdés, T.O, Villar, R., Wyss, F.S
Published 2022

Long-Term Clinical Benefits of Canagliflozin 100 mg versus Sulfonylurea in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin in India

by Gupta, V., Johansen, P., Mane, A., Neslusan, C., Nilsson, A., Shah, M., Willis, M.
Published 2019